EBOS Group (EBO) Stock Overview
Engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
EBO Community Fair Values
Create NarrativeSee what 47 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
EBOS Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$20.85 |
| 52 Week High | NZ$41.98 |
| 52 Week Low | NZ$20.36 |
| Beta | 0.20 |
| 1 Month Change | -6.42% |
| 3 Month Change | -16.60% |
| 1 Year Change | -46.52% |
| 3 Year Change | -52.77% |
| 5 Year Change | -32.52% |
| Change since IPO | 818.77% |
Recent News & Updates
Narrative Update • Apr 24
EBO: Index Removal And Higher Future P/E Will Support Capital Efficiency Reassessment
Analysts have trimmed their EBOS Group price target slightly from about NZ$33.94 to around NZ$33.63, reflecting updated assumptions for revenue growth, profit margins, and a modestly higher future P/E multiple. What's in the News EBOS Group Limited was removed from the S&P/ASX 200 Index, which may influence how some index and rules based funds treat the shares (Key Developments).Narrative Update • Apr 09
EBO: Index Removal And P/E Outlook Will Support Future Capital Efficiency Reassessment
Analysts have nudged their fair value estimate for EBOS Group to NZ$33.94 from NZ$33.59, reflecting slightly updated assumptions for long term profit margins and future P/E multiples, while keeping revenue growth and discount rate broadly unchanged. What's in the News EBOS Group Limited was removed from the S&P/ASX 200 Index, which can affect how some index funds and benchmark aware investors are exposed to the stock (Key Developments).Narrative Update • Mar 25
EBO: Index Removal And P/E Outlook Will Support Future Capital Efficiency Reassessment
Analysts have made a small upward adjustment to EBOS Group's fair value estimate, with the price target moving from around NZ$33.56 to NZ$33.59 as they fine tune assumptions on long term profitability and the future P/E multiple. What's in the News EBOS Group Limited was dropped from the S&P/ASX 200 Index, which may affect index fund ownership and trading volumes for the stock (Key Developments).Narrative Update • Mar 11
EBO: Updated Profit Outlook Will Support Future Capital Efficiency Reassessment
Analysts have trimmed their NZ$ fair value estimate for EBOS Group from NZ$35.22 to NZ$33.56, reflecting updated assumptions for slightly lower revenue growth, a more modest profit margin profile, and a similar forward P/E multiple. What's in the News EBOS Group held an Analyst/Investor Day, which provided an opportunity for management to update the market on the business and the outlook assumptions that feed into valuation work (Key Developments).Recent updates
Narrative Update • Apr 24
EBO: Index Removal And Higher Future P/E Will Support Capital Efficiency Reassessment
Analysts have trimmed their EBOS Group price target slightly from about NZ$33.94 to around NZ$33.63, reflecting updated assumptions for revenue growth, profit margins, and a modestly higher future P/E multiple. What's in the News EBOS Group Limited was removed from the S&P/ASX 200 Index, which may influence how some index and rules based funds treat the shares (Key Developments).Narrative Update • Apr 09
EBO: Index Removal And P/E Outlook Will Support Future Capital Efficiency Reassessment
Analysts have nudged their fair value estimate for EBOS Group to NZ$33.94 from NZ$33.59, reflecting slightly updated assumptions for long term profit margins and future P/E multiples, while keeping revenue growth and discount rate broadly unchanged. What's in the News EBOS Group Limited was removed from the S&P/ASX 200 Index, which can affect how some index funds and benchmark aware investors are exposed to the stock (Key Developments).Narrative Update • Mar 25
EBO: Index Removal And P/E Outlook Will Support Future Capital Efficiency Reassessment
Analysts have made a small upward adjustment to EBOS Group's fair value estimate, with the price target moving from around NZ$33.56 to NZ$33.59 as they fine tune assumptions on long term profitability and the future P/E multiple. What's in the News EBOS Group Limited was dropped from the S&P/ASX 200 Index, which may affect index fund ownership and trading volumes for the stock (Key Developments).Narrative Update • Mar 11
EBO: Updated Profit Outlook Will Support Future Capital Efficiency Reassessment
Analysts have trimmed their NZ$ fair value estimate for EBOS Group from NZ$35.22 to NZ$33.56, reflecting updated assumptions for slightly lower revenue growth, a more modest profit margin profile, and a similar forward P/E multiple. What's in the News EBOS Group held an Analyst/Investor Day, which provided an opportunity for management to update the market on the business and the outlook assumptions that feed into valuation work (Key Developments).Narrative Update • Feb 25
EBO: Lower Forward P/E Reset Will Support Future Capital Efficiency Reassessment
Analysts have trimmed their forward P/E expectations for EBOS Group, prompting a reset in their NZ$ price targets while keeping fair value, revenue growth and profit margin assumptions broadly unchanged. What's in the News EBOS Group held an Analyst/Investor Day, giving the market an updated view on its business outlook, capital allocation priorities and key operating segments (Key Developments).Narrative Update • Feb 11
EBO: Analyst Day Will Support Future Capital Efficiency Reassessment
Analysts have nudged their fair value estimate for EBOS Group higher from A$35.02 to A$35.22, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. What's in the News EBOS Group held an Analyst/Investor Day, providing management with a forum to outline its business priorities and respond to questions from the investment community (Key Developments).Analysis Article • Jan 31
EBOS Group (NZSE:EBO) Will Want To Turn Around Its Return Trends
There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...
New Narrative • Jan 28
Ageing Populations And New Distribution Centers Will Support Long Term Healthcare And Animal Care Demand
Catalysts About EBOS Group EBOS Group is a diversified healthcare and animal care distributor and brand owner operating across Australia, New Zealand and Southeast Asia. What are the underlying business or industry changes driving this perspective?Narrative Update • Jan 27
EBO: Disciplined Bolt On Acquisitions Will Support Future Capital Efficiency
Analysts have modestly adjusted their fair value estimate for EBOS Group to A$35.02 from A$35.38, reflecting fine tuning to revenue growth, profit margin, and future P/E assumptions. What's in the News EBOS Group Limited is scheduled to host an Analyst/Investor Day, giving the market a closer look at its current operations and priorities (Key Developments).Narrative Update • Jan 13
EBO: Distribution Centre Renewal Program Will Support Future Capital Efficiency
Analysts have lifted their fair value estimate for EBOS Group from A$32.64 to A$35.38, citing updated assumptions around revenue growth, profit margins and the future P/E multiple as key drivers of the higher target. What's in the News EBOS Group plans to continue pursuing disciplined bolt on acquisitions, with Chair Elizabeth Coutts stating that the company aims to use these deals to support sustainable growth and create value for shareholders.Analysis Article • Dec 08
EBOS Group Limited's (NZSE:EBO) Price Is Out Of Tune With Earnings
EBOS Group Limited's ( NZSE:EBO ) price-to-earnings (or "P/E") ratio of 23x might make it look like a sell right now...Analysis Article • Oct 30
EBOS Group (NZSE:EBO) Will Want To Turn Around Its Return Trends
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...Narrative Update • Oct 18
Renewed Distribution And Digital Adoption Will Improve Healthcare Supply Chains
Analysts have revised their price target for EBOS Group downward from $36.96 to $32.64. This adjustment is due to lowered revenue growth expectations, while profit margins and discount rates remain stable.Analysis Article • Sep 25
Is EBOS Group (NZSE:EBO) Using Too Much Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Narrative Update • Sep 17
Renewed Distribution And Digital Adoption Will Improve Healthcare Supply Chains
EBOS Group’s consensus price target has been revised downward as a result of an increased future P/E ratio without a meaningful improvement in revenue growth expectations, reducing the fair value estimate from NZ$37.96 to NZ$36.96. What's in the News EBOS Group announced a supplementary dividend distribution of NZD 0.02713235 for the six months ended June 30, 2026; record date is 5 September, ex-date is 4 September, and payment date is 24 September.Analysis Article • Sep 03
EBOS Group's (NZSE:EBO) Weak Earnings May Only Reveal A Part Of The Whole Picture
Last week's earnings announcement from EBOS Group Limited ( NZSE:EBO ) was disappointing to investors, with a sluggish...Analysis Article • Aug 29
EBOS Group's (NZSE:EBO) Dividend Will Be A$0.6421
The board of EBOS Group Limited ( NZSE:EBO ) has announced that it will pay a dividend on the 24th of September, with...Narrative Update • Aug 28
Renewed Distribution And Digital Adoption Will Improve Healthcare Supply Chains
A slight rise in EBOS Group’s future P/E ratio, with virtually unchanged revenue growth forecasts, suggests increased valuation multiples underpin a marginal decrease in the consensus analyst price target from NZ$39.53 to NZ$38.95. Valuation Changes Summary of Valuation Changes for EBOS Group The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from NZ$39.53 to NZ$38.95.Analysis Article • Aug 14
There's Reason For Concern Over EBOS Group Limited's (NZSE:EBO) Price
NZSE:EBO 1 Year Share Price vs Fair Value Explore EBOS Group's Fair Values from the Community and select yours When...Analysis Article • Apr 29
EBOS Group Limited's (NZSE:EBO) Popularity With Investors Is Under Threat From Overpricing
With a price-to-earnings (or "P/E") ratio of 28.2x EBOS Group Limited ( NZSE:EBO ) may be sending very bearish signals...Analysis Article • Mar 30
These 4 Measures Indicate That EBOS Group (NZSE:EBO) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Feb 21
Analyst Estimates: Here's What Brokers Think Of EBOS Group Limited (NZSE:EBO) After Its Half-Year Report
Last week, you might have seen that EBOS Group Limited ( NZSE:EBO ) released its half-yearly result to the market. The...Analysis Article • Feb 11
Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
New Narrative • Feb 09
New High-Value Products And Expansion Into Southeast Asia Will Create Future Opportunities
Strategic acquisitions and new high-value products in healthcare and animal care promise revenue and earnings growth.Analysis Article • Jan 13
Is There An Opportunity With EBOS Group Limited's (NZSE:EBO) 23% Undervaluation?
Key Insights The projected fair value for EBOS Group is NZ$46.90 based on 2 Stage Free Cash Flow to Equity EBOS Group's...Analysis Article • Dec 29
Risks To Shareholder Returns Are Elevated At These Prices For EBOS Group Limited (NZSE:EBO)
When close to half the companies in New Zealand have price-to-earnings ratios (or "P/E's") below 19x, you may consider...Analysis Article • Nov 11
The Returns At EBOS Group (NZSE:EBO) Aren't Growing
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...Analysis Article • Oct 16
Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now
Key Insights EBOS Group to hold its Annual General Meeting on 23rd of October Total pay for CEO John Cullity includes...Analysis Article • Oct 11
Is EBOS Group (NZSE:EBO) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analysis Article • Sep 29
Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analysis Article • Sep 15
An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued
Key Insights EBOS Group's estimated fair value is NZ$46.90 based on 2 Stage Free Cash Flow to Equity EBOS Group's...Analysis Article • Jul 27
Earnings Not Telling The Story For EBOS Group Limited (NZSE:EBO)
With a price-to-earnings (or "P/E") ratio of 24x EBOS Group Limited ( NZSE:EBO ) may be sending bearish signals at the...Analysis Article • Jun 11
Are Investors Undervaluing EBOS Group Limited (NZSE:EBO) By 29%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, EBOS Group fair value estimate is NZ$46.40 EBOS Group is...Analysis Article • May 28
EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Apr 25
EBOS Group (NZSE:EBO) Seems To Use Debt Quite Sensibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Mar 21
Some Confidence Is Lacking In EBOS Group Limited's (NZSE:EBO) P/E
With a price-to-earnings (or "P/E") ratio of 24.7x EBOS Group Limited ( NZSE:EBO ) may be sending bearish signals at...Analysis Article • Feb 24
EBOS Group (NZSE:EBO) Will Pay A Dividend Of A$0.5951
EBOS Group Limited ( NZSE:EBO ) has announced that it will pay a dividend of A$0.5951 per share on the 22nd of March...Analysis Article • Feb 23
EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think
Last week, you might have seen that EBOS Group Limited ( NZSE:EBO ) released its half-yearly result to the market. The...Analysis Article • Jan 23
Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Analysis Article • Dec 18
EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't
EBOS Group Limited's ( NZSE:EBO ) price-to-earnings (or "P/E") ratio of 24.4x might make it look like a strong sell...Analysis Article • Nov 02
An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued
Key Insights The projected fair value for EBOS Group is NZ$46.34 based on 2 Stage Free Cash Flow to Equity EBOS Group's...Analysis Article • Oct 17
Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Oct 02
EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Shareholder Returns
| EBO | NZ Healthcare | NZ Market | |
|---|---|---|---|
| 7D | -4.4% | -1.7% | 0.7% |
| 1Y | -46.5% | -34.0% | 3.2% |
Return vs Industry: EBO underperformed the NZ Healthcare industry which returned -34% over the past year.
Return vs Market: EBO underperformed the NZ Market which returned 3.2% over the past year.
Price Volatility
| EBO volatility | |
|---|---|
| EBO Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in NZ Market | 7.9% |
| 10% least volatile stocks in NZ Market | 2.8% |
Stable Share Price: EBO has not had significant price volatility in the past 3 months compared to the NZ market.
Volatility Over Time: EBO's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1922 | 5,800 | Adam Hall | www.ebosgroup.com |
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
EBOS Group Limited Fundamentals Summary
| EBO fundamental statistics | |
|---|---|
| Market cap | NZ$4.40b |
| Earnings (TTM) | NZ$279.03m |
| Revenue (TTM) | NZ$15.86b |
15.5x
P/E Ratio0.3x
P/S RatioIs EBO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EBO income statement (TTM) | |
|---|---|
| Revenue | AU$13.04b |
| Cost of Revenue | AU$11.34b |
| Gross Profit | AU$1.71b |
| Other Expenses | AU$1.48b |
| Earnings | AU$229.47m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.11 |
| Gross Margin | 13.08% |
| Net Profit Margin | 1.76% |
| Debt/Equity Ratio | 50.7% |
How did EBO perform over the long term?
See historical performance and comparisonDividends
6.3%
Current Dividend Yield93%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/12 15:44 |
| End of Day Share Price | 2026/05/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
EBOS Group Limited is covered by 17 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Brayshaw | Barrenjoey Markets Pty Limited |
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Lyanne Harrison | BofA Global Research |